ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

19 links0 made here, not in the record21 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02348216Study Evaluating the Safetyand Efficacy of KTE-C19 inAdult Participants WithRefractory AggressiveNon-Hodgkin LymphomaKite, A Gilead CompanyPhase 1/Phase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSLymphoma, Large B-Cell, Dif…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSAxicabtagene ciloleucelIntervention entry›As of now · Rule based · BackgroundBackgroundFludarabineIntervention entry›As of now · Rule based · BackgroundBackgroundCyclophosphamideIntervention entry›As of now · Rule based · BackgroundBackgroundLevetiracetamIntervention entry›As of now · Rule based · BackgroundBackgroundTocilizumabIntervention entry›As of now · Rule based · BackgroundBackgroundDexamethasoneIntervention entry›As of now · Rule based · BackgroundBackgroundMethylprednisoloneEntry “High-dose methylprednisolone”,…›As of now · Rule based · BackgroundAs of now · Rule based · BackgroundBackgroundBendamustineIntervention entry›As of now · Rule based · BackgroundBackgroundRituximabIntervention entry›As of now · Rule based · BackgroundBackgroundDoxorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundPrednisoneIntervention entry›As of now · Rule based · BackgroundBackgroundVincristineIntervention entry›As of now · Rule based · BackgroundBackgroundIfosfamideIntervention entry›As of now · Rule based · BackgroundBackgroundCarboplatinIntervention entry›As of now · Rule based · BackgroundBackgroundEtoposideIntervention entry›As of now · Rule based · BackgroundBackgroundGemcitabineIntervention entry›As of now · Rule based · BackgroundBackgroundOxaliplatinIntervention entry›As of now · Rule based · BackgroundBackgroundCisplatinIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lymphoma, Large B-Cell, Diffuse

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryLymphoma, Large B-Cell, Diffuse, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14Lymphoma, Large B-Cell, DiffuseRule based · condition-kind ruleFinest filed termCurrent
As of nowLymphoma, Large B-Cell, DiffuseRule based · main-condition ruleMain conditionCurrent
As of nowAxicabtagene ciloleucelRule based · role ruleBackgroundCurrent
As of nowFludarabineRule based · role ruleBackgroundCurrent
As of nowCyclophosphamideRule based · role ruleBackgroundCurrent
As of nowLevetiracetamRule based · role ruleBackgroundCurrent
As of nowTocilizumabRule based · role ruleBackgroundCurrent
As of nowDexamethasoneRule based · role ruleBackgroundCurrent
As of nowMethylprednisoloneRule based · role ruleBackgroundCurrent
As of nowMethylprednisoloneRule based · role ruleBackgroundCurrent
As of nowBendamustineRule based · role ruleBackgroundCurrent
As of nowRituximabRule based · role ruleBackgroundCurrent
As of nowDoxorubicinRule based · role ruleBackgroundCurrent
As of nowPrednisoneRule based · role ruleBackgroundCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent
As of nowIfosfamideRule based · role ruleBackgroundCurrent
As of nowCarboplatinRule based · role ruleBackgroundCurrent
As of nowEtoposideRule based · role ruleBackgroundCurrent
As of nowGemcitabineRule based · role ruleBackgroundCurrent
As of nowOxaliplatinRule based · role ruleBackgroundCurrent
As of nowCisplatinRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.